The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis
- Resource Type
- Article
- Source
- In
Journal of Neuroimmunology 15 August 2014 273(1-2):31-41 - Subject
- Language
- ISSN
- 0165-5728